The trunk and branches rep the tools & methodologies (Usul al- Fiqh/foundations of Fiqh & Maqasid/Objectives) used by scholars to derive the fruits (fatwas/rulings)
The halal polemics has begun … yet again!
Race and religious bigots will spin to trigger tension
Important to stick to the back of basics of Shari’ah (Islamic jurisprudence) & Research ethics
The relationship between Shari’ah and Fiqh is represented by a tree and its parts.

The trunk and branches rep the tools & methodologies (Usul al- Fiqh/foundations of Fiqh & Maqasid/Objectives) used by scholars to derive the fruits (fatwas/rulings)
The methodology & tools are how pharmacists process the raw ingredients into a medicine
The resulting medicine is dispensed by doctors.
It warrants an alternative prescription.
The relevance of a fatwa would dep on its quality, the societal context & its ability to effectively achieve Maqasid Shari’ah-bringing benefit (maslahah) or removing harm (mafsada).
Global-70 Million cases & 1.6 million deaths
M’sia-78K cases & 396 deaths
A #COVID19 vaccine is one of the solutions to end the pandemic apart from masking, distancing and hygiene
In the absence of clear textual evidence to the contrary everything is permissible
Permissibility (Halal) does not require textual evidence
To say any intervention is not allowed (Haram) requires textual evidence
The burden of proof that a medicine/vaccine/custom (mu’amalat) is impermissible falls on those who repudiate it, not on those who affirm it

It was attended by > 100 Muslim religious scholars and medical experts.

Transformation (istihalah) is the conversion of a substance into another which is different in characteristics.
It changes substances that are judicially impure or are found in an impure environment into pure substances

It changes substances that are prohibited into lawful and permitted substances

e.g. Gelatine in medicines, capsules, vaccines etc

Gelatine is hydrolysed (transformed) into a mixture of amino acids which is not specie specific.

More from Science
A thread on the potential near term catalysts behind why I have increased my position in 4d Pharma @4dpharmaplc (LON: #DDDD):

1) NASDAQ listing. This is the most obvious.
The idea behind this is that the huge pool of capital and institutional interest in the NASDAQ will enable a higher per-share valuation for #DDDD than was achievable in the UK.
Comparators to @4dpharmaplc #DDDD (market capitalisation £150m) on the NASDAQ and their market capitalisation:
Seres Therapeutics: $2.33bn = £1.72bn (has had a successful phase 3 C. difficile trial); from my previous research (below) the chance of #DDDD achieving this at least once is at least
While looking at speculative pharmaceutical stocks I am reminded of why I am averse to these risky picks.#DDDD was compelling enough, though, to break this rule. The 10+ treatments under trial, industry-leading IP portfolio, and comparable undervaluation are inescapable.
— Shrey Srivastava (@BlogShrey) December 16, 2020
Kaleido Biosciences: $347m = £256m. 4 products under consideration, compared to #DDDD's potential 16. When you view @4dpharmaplc's 1000+ patents and AI-driven MicroRx platform (not to mention their end-to-end manufacturing capability), 4d's undervaluation is clear.

2) The leading hypothesis is that the new variant evolved within just one person, chronically infected with the virus for so long it was able to evolve into a new, more infectious form.
same thing happened in Boston in another immunocompromised person that was sick for 155 days.
3) What happened in Boston with one 45 year old man who was highly infectious for 155 days straight before he died... is exactly what scientists think happened in Kent, England that gave rise to #B117.
Immunocompromised 45 year old suffered from #COVID19 for 155 days before he died. The virus was changing very quickly inside the man's body\u2014it acquired a big cluster of >20 mutations\u2014resembled the same ones seen in #B117 & #B1351. (NPR audio Part 1 of 2)\U0001f9f5https://t.co/7kWiBZ1xGk pic.twitter.com/ZJ7AExB78Y
— Eric Feigl-Ding (@DrEricDing) February 8, 2021
4) Doctors were shocked to find virus has evolved many different forms inside of this one immunocompromised man. 20 new mutations in one virus, akin to the #B117. This is possibly how #B1351 in South Africa 🇿🇦 and #P1 in Brazil 🇧🇷 also evolved.
2) NPR report audio part 2 of 2:
— Eric Feigl-Ding (@DrEricDing) February 8, 2021
Dr. Li couldn't believe what they found. "I was shocked," he says. "When I saw the virus sequences, I knew that we were dealing with something completely different and potentially very important." pic.twitter.com/HT3Yt6djFd
5) “On its own, the appearance of a new variant in genomic databases doesn’t tell us much. “That’s just one genome amongst thousands every week. It wouldn’t necessarily stick out,” says Oliver Pybus, a professor of evolution and infectious disease at Oxford.
1.
https://t.co/d5NKtNlxxa
Sounds as if its connected to Bill Gates "LUCIFERASE" Vaccine?
2.
https://t.co/k0w1mjaPg0
"HILLARY RODHAM CLINTON SCHOOL OF LAW"
- AT SWANSEA UNIVERSITY!!!

3.
https://t.co/jifuWq6cGq
Remember all those FIRES, over the Summer!!!
4.
https://t.co/H3lstFyYx8
WUHAN PARTNERSHIP
"Links between Swansea & Wuhan date back to 1855 when Swansea missionary Griffith John founded the Wuhan Union Hospital.
This relationship was strengthened when representatives of the two cities signed an agreement".

5.
https://t.co/5b1JqiEQzi
Swansea University Strengthens Links with China
